Aethlon Medical (AEMD) Debt to Equity (2016 - 2023)
Historic Debt to Equity for Aethlon Medical (AEMD) over the last 13 years, with Q1 2023 value amounting to $0.01.
- Aethlon Medical's Debt to Equity rose 5514.55% to $0.01 in Q1 2023 from the same period last year, while for Mar 2023 it was $0.01, marking a year-over-year increase of 5514.55%. This contributed to the annual value of $0.01 for FY2023, which is 5514.55% up from last year.
- According to the latest figures from Q1 2023, Aethlon Medical's Debt to Equity is $0.01, which was up 5514.55% from $0.01 recorded in Q4 2022.
- Over the past 5 years, Aethlon Medical's Debt to Equity peaked at $4.91 during Q3 2019, and registered a low of $0.0 during Q2 2021.
- In the last 5 years, Aethlon Medical's Debt to Equity had a median value of $0.01 in 2020 and averaged $0.31.
- As far as peak fluctuations go, Aethlon Medical's Debt to Equity soared by 1981550.2% in 2019, and later crashed by 9976.44% in 2020.
- Aethlon Medical's Debt to Equity (Quarter) stood at $0.03 in 2019, then tumbled by 60.59% to $0.01 in 2020, then plummeted by 44.96% to $0.01 in 2021, then skyrocketed by 73.76% to $0.01 in 2022, then rose by 29.06% to $0.01 in 2023.
- Its last three reported values are $0.01 in Q1 2023, $0.01 for Q4 2022, and $0.01 during Q3 2022.